From September 26, 2022 to October 11, 2022, the company has repurchased 1,046,200 shares, representing 0.24% for CNY 30.1 million. With this, the company has completed the repurchase of 1,046,200 shares, representing 0.24% for CNY 30.1 million under the buyback announced on September 26, 2022.
Guangzhou Wondfo Biotech Co.,Ltd
Equities
300482
CNE100002102
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.29 CNY | -1.43% | -1.67% | -6.23% |
May. 06 | Wondfo Biotech's Unit Gets Emergency Use Authorization from US FDA | MT |
Apr. 21 | Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.23% | 1.86B | |
-5.86% | 12.09B | |
-4.87% | 8.21B | |
+5.47% | 5.74B | |
+27.42% | 5.64B | |
-9.89% | 4.16B | |
-58.99% | 2.88B | |
+8.97% | 2.69B | |
-5.19% | 2.33B | |
+21.58% | 2.17B |
- Stock Market
- Equities
- 300482 Stock
- News Guangzhou Wondfo Biotech Co.,Ltd
- Tranche Update on Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback Plan announced on September 26, 2022.